UnitedHealth Group Incorporated (NYSE:UNH) Expected to Post Quarterly Sales of $71.37 Billion

Equities analysts expect UnitedHealth Group Incorporated (NYSE:UNH) to announce sales of $71.37 billion for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for UnitedHealth Group’s earnings, with the highest sales estimate coming in at $72.51 billion and the lowest estimate coming in at $69.84 billion. UnitedHealth Group reported sales of $65.12 billion during the same quarter last year, which suggests a positive year over year growth rate of 9.6%. The company is expected to issue its next earnings results before the market opens on Thursday, October 14th.

According to Zacks, analysts expect that UnitedHealth Group will report full-year sales of $285.18 billion for the current financial year, with estimates ranging from $281.58 billion to $288.71 billion. For the next financial year, analysts anticipate that the business will post sales of $309.03 billion, with estimates ranging from $300.02 billion to $317.34 billion. Zacks’ sales calculations are an average based on a survey of research firms that follow UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.43 by $0.27. The business had revenue of $71.32 billion for the quarter, compared to analyst estimates of $69.51 billion. UnitedHealth Group had a net margin of 5.33% and a return on equity of 22.15%. UnitedHealth Group’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period last year, the firm earned $7.12 earnings per share.

Several equities research analysts recently commented on UNH shares. Citigroup lifted their target price on shares of UnitedHealth Group from $450.00 to $480.00 and gave the stock a “buy” rating in a research report on Friday, July 16th. Seaport Res Ptn reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Friday, July 9th. Truist Securities raised their price target on shares of UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, July 16th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $418.00 to $421.00 and gave the stock a “buy” rating in a report on Tuesday, July 13th. Finally, Truist raised their price target on shares of UnitedHealth Group from $480.00 to $500.00 and gave the stock a “buy” rating in a report on Friday, July 16th. Three research analysts have rated the stock with a hold rating, twenty have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $444.04.

In related news, CEO Andrew Witty sold 6,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 21st. The shares were sold at an average price of $414.15, for a total value of $2,484,900.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO John F. Rex sold 15,438 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 29th. The shares were sold at an average price of $412.04, for a total transaction of $6,361,073.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 101,438 shares of company stock valued at $42,396,929. 0.55% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Amundi purchased a new stake in UnitedHealth Group during the second quarter valued at about $680,292,000. Jennison Associates LLC raised its holdings in shares of UnitedHealth Group by 205.8% during the 2nd quarter. Jennison Associates LLC now owns 1,947,717 shares of the healthcare conglomerate’s stock valued at $779,944,000 after buying an additional 1,310,783 shares in the last quarter. Macquarie Group Ltd. raised its holdings in shares of UnitedHealth Group by 311.9% during the 2nd quarter. Macquarie Group Ltd. now owns 1,622,199 shares of the healthcare conglomerate’s stock valued at $649,595,000 after buying an additional 1,228,389 shares in the last quarter. Fiera Capital Corp raised its holdings in shares of UnitedHealth Group by 99.5% during the 1st quarter. Fiera Capital Corp now owns 2,137,018 shares of the healthcare conglomerate’s stock valued at $795,120,000 after buying an additional 1,065,868 shares in the last quarter. Finally, Capital International Investors raised its holdings in shares of UnitedHealth Group by 5.8% during the 1st quarter. Capital International Investors now owns 18,899,258 shares of the healthcare conglomerate’s stock valued at $7,032,097,000 after buying an additional 1,040,094 shares in the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.

UNH opened at $407.08 on Friday. The company’s 50 day moving average is $415.77 and its 200-day moving average is $401.92. UnitedHealth Group has a 1-year low of $291.22 and a 1-year high of $431.36. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62. The company has a market cap of $383.84 billion, a P/E ratio of 26.89, a PEG ratio of 1.62 and a beta of 0.77.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 21st. Stockholders of record on Monday, September 13th were paid a dividend of $1.45 per share. The ex-dividend date was Friday, September 10th. This represents a $5.80 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is currently 34.36%.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Read More: Liquidity

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.